Literature DB >> 19428276

A novel p.Arg970X mutation in the last exon of the CDKL5 gene resulting in late-onset seizure disorder.

Stavroula Psoni1, Patrick J Willems, Emmanuel Kanavakis, Ariadne Mavrou, Helen Frissyra, Joanne Traeger-Synodinos, Christalena Sofokleous, Periklis Makrythanassis, Sophia Kitsiou-Tzeli.   

Abstract

Classic Rett Syndrome (RS) is a neurodevelopmental disorder due to mutations in the MECP2 gene in Xq28. Atypical RS with severe early-onset encephalopathy and therapy-resistant epilepsy can be due to mutations in the CDKL5 (Cyclin-Dependent Kinase-like 5) gene in Xp22. We here report a 14-year-old female with a RS-like clinical picture, and well-controlled seizures. MECP2 gene testing was negative, but subsequent sequencing of the CDKL5 gene revealed the c. 2908 C>T nonsense mutation (p.Arg970X) in the last exon, not previously described in other patients or controls. The less severe phenotype might be due to the position of the mutation in the last exon of the CDKL5 gene. 2009 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428276     DOI: 10.1016/j.ejpn.2009.03.006

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  8 in total

1.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

2.  A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain.

Authors:  Sarah L Williamson; Laura Giudici; Charlotte Kilstrup-Nielsen; Wendy Gold; Gregory J Pelka; Patrick P L Tam; Andrew Grimm; Dionigio Prodi; Nicoletta Landsberger; John Christodoulou
Journal:  Hum Genet       Date:  2011-07-12       Impact factor: 4.132

Review 3.  Genetics, molecular biology, and phenotypes of x-linked epilepsy.

Authors:  Hao Deng; Wen Zheng; Zhi Song
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

4.  CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.

Authors:  N Bahi-Buisson; T Bienvenu
Journal:  Mol Syndromol       Date:  2011-09-13

5.  Mutations in the C-terminus of CDKL5: proceed with caution.

Authors:  Bertrand Diebold; Chloé Delépine; Svetlana Gataullina; Andrée Delahaye; Juliette Nectoux; Thierry Bienvenu
Journal:  Eur J Hum Genet       Date:  2013-06-12       Impact factor: 4.246

Review 6.  What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy.

Authors:  Charlotte Kilstrup-Nielsen; Laura Rusconi; Paolo La Montanara; Dalila Ciceri; Anna Bergo; Francesco Bedogni; Nicoletta Landsberger
Journal:  Neural Plast       Date:  2012-06-17       Impact factor: 3.599

7.  CDKL5 variants: Improving our understanding of a rare neurologic disorder.

Authors:  Ralph D Hector; Vera M Kalscheuer; Friederike Hennig; Helen Leonard; Jenny Downs; Angus Clarke; Tim A Benke; Judith Armstrong; Mercedes Pineda; Mark E S Bailey; Stuart R Cobb
Journal:  Neurol Genet       Date:  2017-12-15

8.  CDKL5 gene status in female patients with epilepsy and Rett-like features: two new mutations in the catalytic domain.

Authors:  Hiart Maortua; Cristina Martínez-Bouzas; María-Teresa Calvo; Maria-Rosario Domingo; Feliciano Ramos; Ainhoa García-Ribes; María-Jesús Martínez; María-Asunción López-Aríztegui; Nerea Puente; Izaskun Rubio; María-Isabel Tejada
Journal:  BMC Med Genet       Date:  2012-08-06       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.